TCL Archive In the cancer centers: San Antonio Cancer Institute gets a new director, funding commitments. March 12, 2004
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive In Brief: Fredrickson Will Stay As NIH Director; NCI Group to Study Rhoads’ Clinical Center Idea February 11, 1977
TCL Archive Conference asks NCAB To Develop Guidelines For Clinical Alerts; Must Be Investigator-Initiated February 9, 1990
